Company stock · NASDAQ NMS - GLOBAL MARKET · USD

PYXS

Pyxis Oncology Inc

—

Price unavailable — company details still show below

Industry: Biotechnology
Market value: $200.9 million
Number of shares: 119.1 million
Country: US
Went public: Oct 8, 2021
Exchange: NASDAQ NMS - GLOBAL MARKET
Website: pyxisoncology.com
Next earnings: 2026-11-17 · Before open · analysts’ expected profit per share $-0.29

Compare →Earnings calendar →

Price chart Pro

Loading chart…

Company briefing

What PYXS is

Plain English context — why the name shows up in the news, and what to watch next.

In plain English

Pyxis Oncology Inc develops biologic medicines and related therapies, focusing on oncology treatments. The company is a small biotech…

Recent headlines

Live company news for PYXS — each headline includes a ClearTape brief in plain English; open the original for the full story.

Pyxis Oncology: Better Runway Is Bullish For MICVO's Remaining R&DIn brief
Pyxis Oncology’s MICVO drug shows early promise, suggesting a stronger future runway for the company’s remaining research and development efforts. The next step involves optimizing the dosage to improve efficacy and safety.
SeekingAlpha · Oct 4, 2026

Latest on this name

Insights & deeper context

1 recent card — open any for the full deeper dive.

CompanyShort-termUpbeatDays to weeksBenzingaPYXS AMGN

Pyxis Oncology Stock Soars Over 5% Overnight: Here's What You Need to Know

In brief

Pyxis Oncology’s stock climbed after naming a CEO with a strong deal‑making background and gearing up to unveil promising clinical data, sparking short‑term upside and potential long‑term partnership opportunities.

Open card →

Company reports

Official filings (US SEC and linked cards)

No filings here yet

Official report cards for PYXS will show up here when available.

Broad market indexes (like the S&P 500, a basket of 500 large US companies) are shown through popular funds that track them (for example SPY). Company profile and prices use live market data when available.